These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8950904)

  • 1. Measurement of brain natriuretic peptide.
    Murdoch DR; Byrne J; McDonagh T; Morton JJ; McMurray JJ
    Lancet; 1996 Dec; 348(9041):1589. PubMed ID: 8950904
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical detection of systolic dysfunction.
    Sionis A; Bosch X
    Lancet; 1998 Apr; 351(9108):1063; author reply 1063-4. PubMed ID: 9546540
    [No Abstract]   [Full Text] [Related]  

  • 3. Natriuretic peptides in detection of heart failure.
    Dickstein K
    Lancet; 1998 Jan; 351(9095):4. PubMed ID: 9433417
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical detection of systolic dysfunction.
    Omland T
    Lancet; 1998 Apr; 351(9108):1063; author reply 1063-4. PubMed ID: 9546541
    [No Abstract]   [Full Text] [Related]  

  • 5. Validating aminoterminal BNP assays: a word of caution.
    Yandle T; Fisher S; Espiner E; Richards M; Nicholls G
    Lancet; 1999 Mar; 353(9158):1068-9. PubMed ID: 10199361
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospects for using a blood sample in the diagnosis of heart failure.
    Ulahannan TJ
    QJM; 1995 Nov; 88(11):845-6. PubMed ID: 8542270
    [No Abstract]   [Full Text] [Related]  

  • 7. An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction.
    Hughes D; Talwar S; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 1999 Apr; 96(4):373-80. PubMed ID: 10087244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [B-type natriuretic peptide in the differential diagnosis of dyspnea: a useful aid or meaningless ornament? (see the article by Stejskal D. et al: "Personal experience with determination of NT-proBNP in clinical practice" in this issue of Vnitrní Lékarství].
    Kölbel F
    Vnitr Lek; 2003 Feb; 49(2):94-6. PubMed ID: 12728574
    [No Abstract]   [Full Text] [Related]  

  • 9. [The value of natriuretic peptides NT-pro-BNP and BNP for the assessment of left-ventricular volume and function. A prospective study of 150 patients].
    Pfister R; Scholz M; Wielckens K; Erdmann E; Schneider CA
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2605-9. PubMed ID: 12469271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
    Campbell DJ; Mitchelhill KI; Schlicht SM; Booth RJ
    J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of brain natriuretic peptide to predict right ventricular dysfunction and clinical outcome in patients with acute pulmonary embolism.
    Krüger S; Merx MW; Graf J
    Circulation; 2003 Sep; 108(13):e94; author reply e94-5. PubMed ID: 14517156
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated B-type natriuretic peptide levels after anthracycline administration.
    Suzuki T; Hayashi D; Yamazaki T; Mizuno T; Kanda Y; Komuro I; Kurabayashi M; Yamaoki K; Mitani K; Hirai H; Nagai R; Yazaki Y
    Am Heart J; 1998 Aug; 136(2):362-3. PubMed ID: 9704703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal proatrial natriuretic peptide and brain natriuretic peptide are stable for up to 6 hours in whole blood in vitro.
    Davidson NC; Coutie WJ; Struthers AD
    Circulation; 1995 Feb; 91(4):1276-7. PubMed ID: 7850974
    [No Abstract]   [Full Text] [Related]  

  • 14. Utility of brain natriuretic peptide to predict right ventricular dysfunction and clinical outcome in patients with acute pulmonary embolism.
    Thabut G; Logeart D
    Circulation; 2003 Sep; 108(13):e94; author reply e94-5. PubMed ID: 14631970
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients.
    Ortega O; Gallar P; Muñoz M; Rodríguez I; Carreño A; Ortiz M; Molina A; Oliet A; Lozano L; Vigil A
    Nephron Clin Pract; 2004; 97(4):c125-30. PubMed ID: 15331941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease.
    Ribeiro AL; dos Reis AM; Barros MV; de Sousa MR; Rocha AL; Perez AA; Pereira JB; Machado FS; Rocha MO
    Lancet; 2002 Aug; 360(9331):461-2. PubMed ID: 12241721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction.
    Fried I; Bar-Oz B; Algur N; Fried E; Gavri S; Yatsiv I; Perles Z; Rein AJ; Zonis Z; Bass R; Nir A
    Pediatrics; 2006 Oct; 118(4):e1165-8. PubMed ID: 16966393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction.
    Downie PF; Talwar S; Squire IB; Davies JE; Barnett DB; Ng LL
    Clin Sci (Lond); 1999 Sep; 97(3):255-8. PubMed ID: 10464049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations.
    Hobbs FD; Davis RC; Roalfe AK; Hare R; Davies MK
    Heart; 2004 Aug; 90(8):866-70. PubMed ID: 15253955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.